VeriChem
Helping labs and law enforcement find the undetectable in street drugs
Background
Redefining illicit drug identification, ensuring safer communities and swifter justice, is the vision of early-stage technology company VeriChem, a pioneer in creating solutions that solve forensic challenges. The company’s MagLev (Magnetic Levitating) technology addresses a significant challenge posed by the current fentanyl epidemic, as the illicit drug is often mixed with other substances which mask its presence and hinder its timely and accurate detection by traditional methods.
Approach
In 2024, NVision provided strategic consulting to VeriChem to support the company’s early stage fund raising efforts. This included refining the company’s core presentation into a 3-minute format with a narrative script in preparation for a round of investor meetings. Currently, VeriChem is piloting its MagLev technology with forensic labs across the United States, and is also developing the technology for use in the field.
